&nbsp;

Oct 2024

Drug

vanDETanib

Other Name(s): Caprelsa®

Quick Link(s):

Aug 2023

Drug

vemURAFenib

Other Name(s): Zelboraf ®

Quick Link(s):

Aug 2023

Drug

daBRAFenib

Other Name(s): Tafinlar®

Quick Link(s):

Jun 2025

Drug

vismodegib

Other Name(s): Erivedge®

Quick Link(s):

Oct 2023

Drug

daratumumab

Other Name(s): Darzalex®

Quick Link(s):

Jan 2023

Drug

venetoclax

Other Name(s): Venclexta®

Quick Link(s):

Aug 2025

Regimen

VIP

Cancer Type:

Genitourinary,

Testis

Intent: Curative

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2016

Regimen

VIP

Cancer Type:

Gynecologic,

Germ Cell

Intent: Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2018

Regimen

DASA

Cancer Type:

Hematologic,

Leukemia - Chronic Myeloid (CML)

Intent: Palliative

Funding:

Exceptional Access Program

daSAtinib - Ph+ CML in the chronic phase, with specific criteria

Exceptional Access Program

daSAtinib - Accelerated phase or blast phase Ph+ CML with documented resistance or intolerance to imatinib, with specific criteria

Drugs Used:

daSATinib

... Show more tags

Quick Link(s):

Regimen Monograph

Feb 2025

Regimen

DCRB

Cancer Type:

Sarcoma,

Soft Tissue,

Skin,

Melanoma

Intent: Palliative

Drugs Used:

dacarbazine

... Show more tags

Quick Link(s):

Regimen Monograph

Jun 2025

Regimen

DCTN

Cancer Type:

Gynecologic,

Gestational Trophoblastic Disease

Intent: Curative

Drugs Used:

DACTINomycin

... Show more tags